Veritas Bio’s RNA Delivery Patent Allowed by EPO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

JUPITER, Fla.--(BUSINESS WIRE)--Veritas Bio, LLC, a privately held biotechnology company is pleased to announce that the European Patent Office (EPO) has granted a patent to Veritas for European Patent Application No. 07 873 598.2 1401. The patent relates to the “In vivo Delivery of Nucleic Acids.”

Help employers find you! Check out all the jobs and post your resume.